Insmed

Biotech

Insmed Shares Surge on Positive Brensocatib Trial Results for Non-Cystic Fibrosis Bronchiectasis

Insmed (NASDAQ: INSM) has recently been in the spotlight following a significant surge in its stock price. This rise is…

Read More »
Back to top button